Jazz took a step forward with the Chimerix acquisition that should further diversify its revenue base. The oxybate business experienced a setback when Avadel won the appeal that allows Lumryz to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback